A condition called CD3 delta SCID is caused by a mutation in the CD3D gene, which prevents the production of the CD3 delta protein that is needed for the normal development of T cells from blood stem ...

A commonly used scientific method to analyze a tiny amount of DNA in early human embryos fails to accurately reflect gene edits, according to new research. Although gene editing technologies hold ...

The CRISPR-based genome editing toolbox is packed with powerful refinements. The latest of these, prime editing (PE), was first reported in Nature in 2019 by David Liu’s group. Using a prime editing ...

All starting from the same DNA, neurons ultimately take on individual characteristics in the brain and body. Differences in which genes they transcribe into RNA help determine which type of neuron ...

Leading genome editing company Editas Medicine, Inc. EDIT announced that it submitted an Investigational New Drug (IND) application to the FDA for the initiation of a phase I/II study of EDIT-301.

In a paper published on aBIOTECH, the authors investigated the off-target effects of ADAR-mediated RNA editing in rice ...

Editas Medicine, Inc. EDIT announced that the FDA has cleared the initiation of the safety phase of its clinical study on investigational ex vivo gene-editing therapy EDIT-301 being developed for the ...

Scientists have successfully created animal surrogate fathers that carry only the genes of donor animals – nicknamed “super dads” – in a step forward for gene editing with potential implications for ...

Please provide your email address to receive an email when new articles are posted on . A single-dose CRISPR gene-editing infusion lowered blood PCSK9 in three patients with HeFH and advanced CAD. One ...

Gene-editing tool CRISPR-Cas9 has garnered significant amounts of positive press in recent months, as the promise of gene editing could help with medicine and alter DNA for the better. But a new study ...